108 related articles for article (PubMed ID: 6372996)
21. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
Shawler DL; Glassy MC; Wormsley SB; Royston I
J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
[TBL] [Abstract][Full Text] [Related]
22. Serological analysis of cell surface antigens of HL-60 cells before and after treatment with a phorbol ester tumor promoter.
Namikawa R; Ogata S; Ueda R; Tsuge I; Nishida K; Minami S; Koike K; Suchi T; Ota K; Iijima S; Takahashi T
Leuk Res; 1983; 7(3):375-87. PubMed ID: 6604202
[TBL] [Abstract][Full Text] [Related]
23. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.
Nagasawa K; Howatson A; Mak TW
J Cell Physiol; 1981 Oct; 109(1):181-92. PubMed ID: 6976970
[TBL] [Abstract][Full Text] [Related]
24. Sialyltransferase activity as a marker for the differentiation of lymphocytes. Increase in sialyltransferase activity of blasts from acute lymphoblastic leukaemia cases by 12-o-tetradecanoylphorbol-13-acetate (TPA).
Sasaki R; Takaku F; Lin YL; Bollum FJ
Clin Exp Immunol; 1982 Feb; 47(2):381-8. PubMed ID: 6951664
[TBL] [Abstract][Full Text] [Related]
25. Phorbol ester-resistant monoblastoid leukemia cells with a functional mitogen-activated protein kinase cascade but without responsive protein tyrosine phosphatases.
Seimiya H; Sawabe T; Toho M; Tsuruo T
Oncogene; 1995 Nov; 11(10):2047-54. PubMed ID: 7478524
[TBL] [Abstract][Full Text] [Related]
26. Preferential growth inhibition of human leukemic versus normal myeloid colony-forming cells by 12-O-tetradecanoylphorbol-13-acetate.
Park CH
Exp Hematol; 1984 Jun; 12(5):285-90. PubMed ID: 6723821
[TBL] [Abstract][Full Text] [Related]
27. Tumor-promoting phorbol diester-induced specific changes in cell surface glycoprotein profile of K562 human leukemic cells.
Fukuda M
Cancer Res; 1981 Nov; 41(11 Pt 1):4621-8. PubMed ID: 7306980
[TBL] [Abstract][Full Text] [Related]
28. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
29. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate.
Guy K; Van Heyningen V; Dewar E; Steel CM
Eur J Immunol; 1983 Feb; 13(2):156-9. PubMed ID: 6403357
[TBL] [Abstract][Full Text] [Related]
30. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
31. In vitro study of translocation t(4;11) acute leukemia. Sequential range of phenotype.
Léglise MC; Rivière D; Le Calvez G; Le Bris MJ; Sensebé L; Brière J
Arch Pathol Lab Med; 1989 Feb; 113(2):164-8. PubMed ID: 2916903
[TBL] [Abstract][Full Text] [Related]
32. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.
Montuori N; Selleri C; Risitano AM; Raiola AM; Ragno P; Del Vecchio L; Rotoli B; Rossi G
Clin Cancer Res; 1999 Jun; 5(6):1465-72. PubMed ID: 10389934
[TBL] [Abstract][Full Text] [Related]
33. [Induction of differentiation of human myelomonocytic cell lines by chemical inducers: analysis of surface antigens with monoclonal antibodies].
Yamada K; Okabe N; Saito H; Suzuki R
Nihon Ketsueki Gakkai Zasshi; 1984 May; 47(3):703-8. PubMed ID: 6591672
[No Abstract] [Full Text] [Related]
34. Differentiation and the multiple drug resistance phenotype in human leukemic cells.
Beck WT; Cirtain MC; Ashmun RA; Mirro J
Cancer Res; 1986 Sep; 46(9):4571-5. PubMed ID: 3015390
[TBL] [Abstract][Full Text] [Related]
35. Regulation of CD9 expression during 12-O-tetradecanoyl-phorbol-13-acetate- induced differentiation of human myeloid leukemia (HL-60) cells.
Xu M; Chen L; Christman JK
Cell Growth Differ; 1994 Nov; 5(11):1225-34. PubMed ID: 7848923
[TBL] [Abstract][Full Text] [Related]
36. In vitro induction of myeloid surface markers in a rare case of acute leukemia.
Drexler HG; Coustan-Smith E; Gignac SM; Jani H; Hoffbrand AV
Am J Hematol; 1987 Aug; 25(4):441-8. PubMed ID: 3303919
[TBL] [Abstract][Full Text] [Related]
37. Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia.
Koeffler HP; Bar-Eli M; Territo M
J Clin Invest; 1980 Nov; 66(5):1101-8. PubMed ID: 6253522
[TBL] [Abstract][Full Text] [Related]
38. Effects of 12-O-tetradecanoylphorbol-13-acetate on the proliferation and differentiation of normal and leukemic myeloid progenitor cells.
Ozawa K; Miura Y; Hashimoto Y; Kimura Y; Urabe A; Takaku F
Cancer Res; 1983 May; 43(5):2306-10. PubMed ID: 6831455
[TBL] [Abstract][Full Text] [Related]
39. Membrane lipid dynamics in human promyelocytic leukemia cells sensitive and resistant to 12-O-tetradecanoylphorbol-13-acetate induction of differentiation.
Fisher PB; Schachter D; Abbott RE; Callaham MF; Huberman E
Cancer Res; 1984 Dec; 44(12 Pt 1):5550-4. PubMed ID: 6594192
[TBL] [Abstract][Full Text] [Related]
40. [Expression of HLA-DR structure and a membrane-specific antigen by a granulocytopoietic line of acute leukemic blast cells].
Palumbo A; Giovinazzo B; Marmont F; Garbarino G; Paolino F; Pegoraro L
Boll Soc Ital Biol Sper; 1982 Mar; 58(6):271-4. PubMed ID: 6952888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
